Forlong Biotechnology
About
What does Forlong Biotechnology do?
Forlong Biotechnology is a clinical-stage biotechnology company focused on developing transformative cytokine therapies for patients with severe unmet medical needs. The company recently completed a Series Pre-B financing round of RMB 120 million (approximately USD 17.5 million).
What is Forlong Biotechnology's revenue?
StartupHub estimates Forlong Biotechnology's annual revenue at $3.4M (range $1.2M to $10.0M, 34% confidence), based on comparable companies in the sector.
What is Forlong Biotechnology's valuation?
StartupHub estimates Forlong Biotechnology's effective valuation at $86.4M (range $56.3M to $135.0M, 13% confidence), based on comparable companies in the sector.
How much funding has Forlong Biotechnology raised?
Forlong Biotechnology has raised a total of $23M in funding. The most recent round on record is Series Pre-B.
Where is Forlong Biotechnology headquartered?
Forlong Biotechnology is headquartered in Shanghai, China.
What industry does Forlong Biotechnology operate in?
Forlong Biotechnology operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, Drug Discovery, Clinical Trials.
What is Forlong Biotechnology's current status?
Forlong Biotechnology's current operating status is: Inactive.
No comments yet. Be the first to share your take.